Abstract: The present invention relates to the preparation of therapeutic compositions comprising of fermented soy extracts made with lactic acid bacteria and the optional addition of at least a yeast. The invention also relates to therapeutic uses of such extracts in promoting general health, improving the health of subjects, preventing and/or treating cancer, preventing infections, reducing the incidence of infections, treating infections, treating asthma, treating inflammation, modulating the immune system and treating immune disorders.

Abstract: The present invention relates to a process of providing an extract containing at least one simmondsin compound. The extract is provided from jojoba plant, and used as a dietary supplement for use in a weight control regiment in humans. The present invention also provides a method of treating an overweight human in need of such treatment, and comprises administering a therapeutically effective amount of such an extract.

Abstract: Supplement compositions designed to support healthy lung function and to help strengthen the immune system.

Abstract: A nutraceutical composition containing 0.01-99% by weight polysaccharides enriched from an extract of beans of Glycine max (L.) Merr. Also disclosed are a method of enriching polysaccharides from pulverized beans of Glycine max (L.) Merr.; a polysaccharide having a backbone of ?-(1,6)-linked glucose residues, and one or more galactose or mannose residues are bonded to the C-3 or C-4 position of one or more of the glucose residues by a (1,3)- or a (1,4)-linkage; and a method of treating a subject with such polysaccharides to increase blood cell counts.

Abstract: Materials with high levels of unsaponifiable matter, such as extracts from plants, result in Hydrolysates with unique properties. It has been found that the application of a hydrolysis process to materials, particularly materials with a high level of unsaponifiables (e.g., at least 6% by total weight of the material) produces a product with properties significantly different from those products resulting from the conventional saponification of materials with less than 6% by weight of unsaponifiables. The resulting Hydrolysates from the practice of the present invention are substantive, resisting both physical and aqueous-based removal from skin and hair, exhibit a very unique surfactant property, and are not foaming agents with water. Addition of extra alkali metal hydroxides to these Hydrolysates according to the present invention may thus be used to neutralized acidic gelling agents and thereby providing a gel with enhanced the performance for cosmetics and pharmaceuticals.

Abstract: The present invention provides an ingestible composition comprising a plurality of components consisting of fat, carbohydrates, proteins, vitamins and minerals, wherein relative amounts of the components of the composition are chosen such that an intake of said product reduces the effects of metabolic syndrome.

Abstract: A composition and method for facilitating weight loss and aiding in the maintenance of a stable weight in humans, wherein a preferred embodiment of the chemical composition comprises a mixture of psyllium husks generally in an amount of between 72% and 88% by weight of the total chemical composition, natural marine shellfish extract, such as a high density chitosan generally in an amount of between 9% and 11% by weight, acacia generally in an amount of between 4.5% and 5.5% by weight, an amount of apple pectin generally in an amount of between 1.4% and 2.2% by weight of the total chemical composition, ascorbic acid (Vitamin C) generally in an amount of between 1.8% and 2.2% by weight. An excipient may also be included generally in an amount of about 1% by weight of the total chemical composition. The method includes having a person ingest one or more unit dosages of the foregoing chemical composition with generally about eight ounces of water prior to a meal.

Abstract: A topical composition which enhances sexual responsiveness of a mammal is disclosed. An effective dosage of a peripheral vasodilator, an absorption enhancer and, optionally, a vasoconstrictor and an alpha receptor blocker are combined with a pharmaceutically-acceptable topical vehicle to produce the composition. The compositions are applied topically to the penis or labia majora and minora pudenda to enhance erection or vasocongestion.

Abstract: A topical composition for the protection of skin from damage caused by ultraviolet radiation. The composition includes a jojoba extract that absorbs ultraviolet radiation having one or more wavelengths between about 290 nanometers and about 400 nanometers. The composition further includes a jojoba extract comprising a plurality of antioxidant compounds comprising a ferulic acid moiety. The topical compositions are incorporated into sunscreen products, soap, moisturizing lotions, skin toners, and other skin care products.

Abstract: Non-estrogen-dependent hyperproliferation of cells in animals or humans can be prevented or treated by means of a pharmaceutical or nutritional composition containing a combination of at least three components from: a) two or more inhibitors of the G1/S phase of the cell cycle; and b) two or more inhibitors of the G2/M phase of the cell cycle; and c) two or more inhibitors of protein tyrosine kinase activity. Especially, component a) comprises two or more compounds selected from flavanolignans, carotenoids and isoflavones; component b) comprises two or more compounds selected from flavanolignans, hydroxylated stilbenes, isoflavones and apigenin; and component c) comprises two or more compounds selected from flavanolignans and isoflavones.

Abstract: A chemical composition including asafetida, ajwain seed, videnga, cumin seeds, fenugreek, triphala, fennel seed, and turmeric and the method of use thereof as a treatment for relieving headache, blood constipation, tapeworm, hemorrhoid, constipation and stomach acidity symptoms.

Abstract: A novel peptidoglycan compositions are offered for inhibition of apoptosis of hematopoietic cells. The active ingredient is N-acetyl-glucosamine-N-muramyl L-alanine-D-isoglutamine-meso-diaminopimelyl-D-alanine (GMTP). Its cytoprotective effect allows to treat leucopenia, anemia, and thrombocytopenia.

Abstract: An anti-atypical pneumonia decoction where a Chinese medicinal formula comprises the following medicinal materials: scutellaria root 0.5˜10 weight parts, gardenia 0.5˜10 weight parts, honeysuckle flower 0.5˜10 weight parts, weeping forsythia 0.5˜10 weight parts, dried rehmannia root 0.5˜10 weight parts, gypsum 0.5˜10 weight parts, flos chrysanthemi indici 0.5˜10 weight parts, basket fem 0.5˜10 weight parts, balloonflower root 0.5˜10 weight parts, mint 0.5˜10 weight parts, arctium fruit 0.5˜10 weight parts, and liquorice 0.5˜10 weight parts. Those medicinal materials were decocted with water to obtain the anti-atypical pneumonia decoction. The anti-atypical pneumonia decoction of the invention has satisfactory effect for preventing and treating atypical pneumonia or suspected atypical pneumonia.

Abstract: This invention refers to the preparation for elimination of neuropathies in diabetes. The preparation contains a combination of minerals and plant extracts. By its ionic exchange, the invention reduces considerably the process of apoptosis of nerve-cells, eliminates the process of activation of the immunologic system, and stops the immunologic reaction of auto-destruction of nerve-cells. Depositing of immunoglobulin on axons is absent, and neuropathic pain disappears. Furthermore, the preparation reduces the activity of free radicals, improves the regulation of glycemia and improves the recovery of axons which are already damaged.

Abstract: This invention provides compositions and methods related to the administration of psyllium husk, Î2-sitosterol, guggul tree extract, guar gum and chromium as a combination to reduce or control blood cholesterol, triglycerides, low density lipoproteins, blood sugar or increasing or controlling high density lipoproteins in a mammal, to reduce arterial plaque build-up, atherosclerosis, in a mammal which may be associated with cardiovascular, cerebrovascular, peripheral vascular, or intestinal vascular disorders.

Abstract: The perioperative multivitamin protein bar for promoting an anabolic state in a person is made of from about 250 mg to about 2500 mg of a digestive enzyme, such as bromelain, pepsin, amylase, protease, lipase, cellulase, lactase, alpha-g, glucoamylase, invertase, malt diastase, pectinase, xylanase, bromelain, betain, trypsin, or combinations thereof; from about 50 mg to about 2500 mg of an amino acid; from about 200 mg to about 2000 mg of a sea plant; from about 10 mg to about 8000 mg of a flavoring; from about 100 mg to about 2500 mg of Vitamin A, Vitamin B, Vitamin D, Vitamin E, Vitamin K, calcium, complexes thereof, or combinations thereof; and from about 1000 mg to about 9000 mg of a fiber.

Abstract: This invention relates to an agent for treating or preventing allergic disease comprising, as an active ingredient, a treated product of peanut seed coats.

Abstract: A therapeutic herbal composition comprising Saw Palmetto, Bromelain, Willow Herb, Grape Seed Complex, Wild Rosella, Liquorice, Passionfruit Seed and Selenium Yeast is claimed. The composition may be used as a general health promotant but is also useful as a treatment of cancer and inflammation. Prostrate cancer and hyperplasia may be particularly beneficially addressed with the composition. The invention extends to a method of treatment using a composition as described.

Abstract: A composition with dehydration preventive ingredients, is essentially comprised of calcium carbonate and organic substances extracted from powder of Perla Perla, Atractylis ovata Thunb, Poria cocos Wolf, Alisma plantago-aquatica L., P. Hoelen Rumph, Clcyrrhiza glabra L., Cinnamomum loureiru Nees, and saccharin to be infused in water for drink before meal to quench thirst, prevent diarrhea, alleviate food poisoning, and to avoid dehydration and make up loss of electrolytes due to vomit for alleviating discomfort.

Abstract: Described are skin-care compositions containing non denatured soy products and optionally other anti-cancer or anti-aging agents. The compositions can be applied topically to reduce the risk of UV-induced cutaneous tumors.

Abstract: A process for manufacturing shoe insoles with antibacterial and foot odor activity mixes Angelica, Ligussticum sp., Menthae Herba, Mugwort, charcoal, and Osterium koreanum in a predetermined weight ratio with a subsidiary component into a composition. Outer, first and second fabric sheets are cut into predetermined suitable sizes and laminated. An inlet is formed at a toe region of the laminate into a pocket that is filled with the herbal composition. A finish sheet is sewn on the laminate, the finish sheet being hemp or wool fabric. Holes are formed at predetermined intervals on the inside face and snap type buttons are fixed at the holes by pressing.

Abstract: A topical treatment for functional constipation in humans, wherein active herb encouraging the peristaltic movement of the stomach and the intestines, increasing water secretion is invented by applying an herbal topical preparation inside and/or around the navel. The treatment results in a significant non-invasive relief of functional constipation without discomfort.

Abstract: A composition for the relief and/or prevention of climacteric and menopausal disorders affecting women in pre-, peri- or post-menopause, comprising Soy Isoflavones and viable lactic acid bacteria preferably Lactobacillus sporogenes aimed to enhance the absorption of Soy Isoflavones, the composition being provided in dosage forms for oral administration. Preferably the composition also comprises Equisetum arvense dry extract and a pharmaceutically acceptable calcium salt and/or Vitamin D3.

Abstract: A composition for reducing blood sugar in humans in need thereof, contains Agaricus blazeii, alpha lipoic acid, transfer factor, polymannose, fenugreek, coenzyme Q-10, selenium, zinc, vitamin C, vitamin E, chromium and vanadium.

Abstract: The invention concerns soy protein, phytoestrogens, phospholipids, and dietary fibers and compositions thereof suitable for preventing, treating and/or alleviating cardiovascular diseases such as hypercholesterolemia, hypertriglyceridemia, hyperlipidemia arteriosclerosis, hypertension and related cardiovascular diseases, for preventing and/or treating type 2 diabetes and/or the metabolic syndrome, and for preventing, treating and/or alleviating pulmonary diseases.

Abstract: The invention provides methods and compositions for use in culturing Clostridium difficile and producing Clostridium difficile toxins.

Abstract: The present invention relates to a naturally derived cosmetic material obtained from bean broth, or by being fermented it or treating it with enzymes, and to a manufacturing method thereof. The method for manufacturing the cosmetic material of the present invention is characterized in that beans are added to a water-based solvent and heated, and the bean broth thus obtained is subjected to fractional purification, to inoculation with Bacillus natto and fermentation culturing, or to the action of soybean Aspergillus bacteria-derived proteases. Because the cosmetic material obtained by this method has excellent SOD activity, cytotonic activity, collagen-formation accelerating ability, antibacterial activity, and tyrosinase inhibiting action, this cosmetic material inhibits the peroxidation of skin lipids and prevents skin aging, and can be appropriately used as a beauty product having excellent functionality in the skin.

Abstract: The present invention provides a composition and methods of using composition consisting essentially of a soy component, chasteberry, clover, and black cohosh, in a suitable carrier, optionally with each of the soy component, chasteberry, clover, and black cohosh is enrobed in a glycoprotein matrix.

Abstract: The invention relates to a multifunctional fiber rich fraction (FRF) useful as an excipient for pharmaceutical dosage forms for various routes of administration. This excipient can be used as binder, disintegrant, filler, dispersing agent, coating agent, film forming agent, thickener etc for preparation of variety of dosage forms. This FRF can also be used in a controlled release, targeted release and other specialized delivery systems, as well as in food and cosmetics formulation.

Abstract: The present invention relates to a side effect-relieving agent for thiazolidine compounds which comprises a crude drug as an active ingredient comprising Ephedrae Herba, Glycyrrhizae Radix and Gypsum Fibrosum each of which is in a form of ground powders, extracts or mixtures of powders and extracts; and a hypoglycemic effect enhancer for thiazolidine compounds which comprises a crude drug as an active ingredient comprising Ephedrae Herba, Glycyrrhizae Radix and Gypsum Fibrosum each of which is in a form of ground powders, extracts or mixtures of powders and extracts. Using the preparation according to the present invention, body weight gain, which is a side effect of thiazolidine compounds, can be relieved and the hypoglycemic effect of the thiazolidine compounds can be enhanced.

Abstract: The present invention provides a skin aging-preventing or improving agent. The agent contains a substance capable of enhancing the expression level of Rho kinase or myosin light-chain kinase. According to the present invention, aging of the skin such as sagging of the skin, wrinkle formation, or loss of skin elasticity can be prevented or the skin can be improved.

Abstract: The present invention relates to a herbal health protective, promotive neutraceutical formulation for women, human expectant mothers and lactating mothers, and also relates to a process for the preparation of custom made herbal health protective, promotive nutraceutical formulations as food supplements to ameliorate the general health of females with optimum nutrients, said process comprises the base product of microwave oven roasted seed powders mixture from selected genera of Glycine, Phaseolus, Cicer, Psophocarpus, Mucuna, Triticum, Hordeum, Amaranthus, Chenopodium and Fagopyrum, fortified with the natural herbs/medicinal plants extract from the genera Centella, Withania, Pueraria, Asparagus, Chlorophytum, Boerhaavia, Sida, Saraca and also some other ingredients like pale sugar powder, jaggery, milk powder, coca powder, Elettaria cardamomum (Elaichi) powder, Piper longum (Pippali) fruit powder, Myristica fragrans (Jaiphal) fruit powder were also added to get the final nutraceuticals; the nutraceuticals are

Abstract: A process of using a fermented Glycine max (L.) extract comprising the steps of: mixing natural nutrient with medium solution to produce an agar medium; transferring various kinds of lactic acid bacteria and yeast into said agar medium and placing them into a thermostat for pure incubation; inoculating lactic acid bacteria and yeast and said agar medium to said soybean medium and incubating all bacteria in thermostat; separating said lactic acid bacteria and yeast from each other and transferring them into said organic soybean medium and starting acclimatized incubation; transferring all lactic acid bacteria and yeast from grouping incubation to said organic soybean medium and starting symbiotic incubation to form said fermented Glycine max (L.) extract, whereby the extract can be used for enhancing natural killer cell activity and inhibitory activities to GABA and glutamate receptor binding for prolonging sleeping time and reducing fatigue in cancer patients during chemotherapy was conducted.

Abstract: A nutritional intervention composition for reducing post-prandial blood glucose levels in humans, including between about 0.1 mg and about 500 mg of a proteinase inhibitor that is administered prior to the meal. The composition is effective for treating or ameliorating the effects of hyperglycemia and Type II diabetes. The composition also is effective in combating obesity. The proteinase inhibitor is preferably isolated from plant material, such as potatoes, soy, and beans. Potato proteinase inhibitor II and soybean Bowman-Birk inhibitor are included in the group of effective proteinase inhibitors.

Abstract: Precipitation fractionation of an aqueous extract of soybeans by addition of an organic solvent such as ethanol or molecular weight fractionation of the extract by ultrafiltration or size exclusion chromatography is appropriately combined with activated carbon filtration, cation- or anion-exchange resin treatment or other adsorbent (e.g., polyamide or octadecylsilica) treatment to provide a nicotianamine product of desired purity. The product is added to food and drink to provide health foods.

Abstract: The invention provides cosmetics or dermatological compositions comprising plant extract or whey extract having an action to potentiate laminin 5 productivity in the epidermal cells. They have mainly the action and efficacy to prevent or improve aging in the skin.

Abstract: Novel food, dietary supplement and nutraceutical products containing phenol/protein complexes derived from vegetable sources have high antioxidant activity and very high levels of protein. The products provide novel means for administering high levels of plant antioxidants to human and mammals in the form of a protein concentrate. Due to their high antioxidant capacity these novel products are useful as aids in the prevention and treatment of many diseases.

Abstract: There is provided a natural composition for boosting the libido of an individual, the composition including an effective amount of an aphrodisiac and a compound to increase blood flow to the pelvic area in a pharmaceutically acceptable carrier. A natural composition for boosting the libido of an individual, including an effective amount of a compound for driving blood flow to the penis and an aphrodisiac in a pharmaceutically acceptable carrier is also provided. Also provided is a method of increasing the libido by administering an effective amount of composition including an aphrodisiac and a compound to increase blood flow to the pelvic area in a pharmaceutically acceptable carrier.

Abstract: An anti-tumor pharmaceutical composition comprises the conjugation of Canavalia ensiformis-extracted protein with metal ions to form a metalloprotein complex for inhibiting the growth of tumor with enhanced activity and stability, but without toxicity.

Abstract: The present invention relates to compositions for the protection, treatment and repair of connective tissues in humans and animals comprising any or all of anabolic, anti-catabolic, anti-oxidant and analgesic agents, including aminosugars, S-adenosylmethionine, arachadonic acid, GAGs, including pentosan, collagen type II, tetracyclines or tetracycline-like compounds, diacerin, super oxide dismutase, L-ergothionine, one or more avocado/soybean unsaponifiables, and an analgesic, e.g., acetaminophen, and to methods of treating humans and animals by administration of these novel compositions to humans and animals in need thereof.

Abstract: The present invention is directed to a topical insect repellent composition, comprising: 40-70 wt % eucalyptus oil; 3-10 wt % catnip oil; 2-6 wt % DMSO or MSM; 6-20 wt % aloe vera; 6-20 wt % jojoba oil; 6-20 wt % tea tree oil; and 6-20 wt % peppermint oil, all weight percents based on the total weight of the composition. The present invention is also directed to an article of manufacture that contains a label and the composition of the invention.

Abstract: A process of making a supplement for digestive ailment includes the steps of (a) soaking a raw composition which consists of 39.22% by weight of Radix Angelicae Sinensis, 39.22% by weight of Radix Paeoniae Alba, 3.92% by weight of Semen Arecae, 5.88% by weight of Talcum, 1.96% by weight of Radix Saussureae Lappae, 1.96% by weight of Semen Raphani, 3.92% by weight of Fructus Aurantii, and 3.92% by weight of Radix Glycyrrhizae, in a predetermined volume of water for a predetermined soaking time to form a pre-decocting solution and a pre-decocting composition; (b) heating said pre-decocting solution and said pre-decocting composition for a predetermined period of decocting time to form a mixture consisting of a residual composition and a supplement in solution; wherein a volume ratio of said supplement in solution and said water in the step (a) is approximately 1:3; and (c) separating said residual composition and said supplement in solution.

Abstract: Unhydrolyzed and hydrolyzed jojoba protein having high simmondsin concentration are provided. These jojoba proteins may be in the form of an aqueous dispersion containing a mixture of amino acids, peptides and/or protein fractions derived from the extraction and hydrolysis of naturally occurring jojoba protein, or dried into a powder.

Abstract: A process for the production of a high purity isoflavone composition is disclosed. The process involves subjecting plant material to a primary chromatographic step to obtain an isoflavone enriched fraction and subjecting the isoflavone enriched fraction to a second chromatographic step. Also disclosed is a process that invloves passing the plant material through an ultrafiltration membrane which has a molecular weight cut-off range that produces a plant material permeate prior to subjecting the plant material permeate to primary and secondary chromatographic steps.

Abstract: The present invention is for compositions containing phaseolamin and a mineral, such as chromium or vanadium or both, where the mineral is bound by a glycoprotein matrix. The present invention is also directed to methods for controlling carbohydrate cravings, inducing weight loss, reducing insulin requirements in a diabetic, and inhibiting the absorption of dietary starch by administering a composition of the invention.

Abstract: The present invention relates to compositions for the protection, treatment and repair of connective tissues in humans and animals comprising any or all of anabolic, anti-catabolic, anti-oxidant and analgesic agents, including aminosugars, S-adenosylmethionine, arachadonic acid, GAGs, including pentosan, collagen type II, tetracyclines or tetracycline-like compounds, diacerin, super oxide dismutase, L-ergothionine, one or more avocado/soybean unsaponifiables, and an analgesic, e.g., acetaminophen, and to methods of treating humans and animals by administration of these novel compositions to humans and animals in need thereof.

Abstract: A process to obtain a highly soluble, low viscosity, salt tolerant gelling vegetable protein product. When introduced into a suitable meat injection brine, the protein product is capable of forming a firm sliceable meat piece with high water retention and no visible signs of the injected brine. When included in gel-based food products such as meat analog formulas, the protein product is capable of forming the desired gel structure, such as firm, sliceable meat-like pieces.

Abstract: An innovative health food for good sleepy is provided for improving the factors that interfere with sleep as much as possible and is suitable for attaining good sleep and deep sleep mainly comprising herbal medicines in combination. The health food for good sleep contains a Panax ginseng extract, a Ginkgo biloba leaf extract, a Ganoderma lucidum extract, and calcium, which are mixed together in predetermined proportions. For example, the mixture contains 0.5 to 1.0 parts by weight of the Ginkgo biloba leaf extract, 0.1 to 0.5 parts by weight of the Ganoderma lucidum extract, and 0.1 to 1.0 parts by weight of calcium with respect to 1 part by weight of the Panax ginseng extract.

Abstract: This invention discloses a topical herbal formulation for preventing and/or treating dyshidrosis (pompholyx), non-responsive to topical steroids. The formulation may also be used to treat contact dermatitis, eczema, palmoplantar pustulosis and skin infections incurred by invasive pathogens such as mold, fungus and bacteria. The formulation is comprised of plant extracts and niacin, that when combined yield an effective multi-faceted pharmaceutical approach to treating dry skin disorders. The active ingredients within the formula include a combination of dry, aqueous, acid and alcohol extracts of black walnut hull (Juglans Nigra), wormwood (Artemisia Absinthium), tumeric rhizome (Curcuma Longa), garlic (Allium sativum), chamomile (Matricaria Chamomile), licorice root (Glycyrrhiza Glabra), St Johns wort (Hypericum perforatum), aloe vera, niacin and herbal anti-bacterial agents.

Abstract: The present invention relates to dietary supplementing methods useful for controlling obesity. More particularly, the invention relates to methods of administration of compositions containing defined chemical species useful for prevention and treatment of obesity. In a preferred embodiment, pharmaceutical compositions used in connection with the present invention comprise: (1) a zinc salt, (2) cyclo-Hispro and/or (3) arachidonic acid, and (4) at least one pharmaceutically acceptable excipient. More particularly, the invention relates to methods of manufacturing of preparing a soybean protein hydrolysate (SPH) comprising cyclo-Hispro.